{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:06:00Z","timestamp":1791345960798,"version":"4.3.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T00:00:00Z","timestamp":1377475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ajpath.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T21:45:14Z","timestamp":1377639914000},"page":"1113-1124","source":"Crossref","is-referenced-by-count":282,"title":["Molecular and Cellular Heterogeneity in Breast Cancer"],"prefix":"10.1016","volume":"183","author":[{"given":"Ashley G.","family":"Rivenbark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan M.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.08.002_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2013.08.002_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2013.08.002_bib3","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/hmg\/10.18.1907","article-title":"Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions","volume":"10","author":"Kurose","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2013.08.002_bib4","first-page":"305","article-title":"Multi-step process of human breast carcinogenesis: a role for BRCA1, BECN1, CCND1, PTEN and UVRAG","volume":"5","author":"Wu","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ajpath.2013.08.002_bib5","first-page":"5615","article-title":"Breast cancer epidemiology","volume":"48","author":"Kelsey","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13402-011-0010-3","article-title":"Pathology of hereditary breast cancer","volume":"34","author":"van der Groep","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"issue":"Suppl 2","key":"10.1016\/j.ajpath.2013.08.002_bib7","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/modpathol.2010.37","article-title":"Pathology of hereditary breast cancer","volume":"23","author":"Da Silva","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jnci\/50.5.1111","article-title":"On the origin and progression of ductal carcinoma in the human breast","volume":"50","author":"Wellings","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2013.08.002_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.yexmp.2012.10.018","article-title":"Field cancerization in mammary carcinogenesis\u2013implications for prevention and treatment of breast cancer","volume":"93","author":"Rivenbark","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2013.08.002_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2013.08.002_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnci\/djp485","article-title":"National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009","volume":"102","author":"Allegra","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2013.08.002_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jncimonographs\/lgq035","article-title":"Ductal carcinoma in situ: terminology, classification, and natural history","volume":"2010","author":"Allred","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ajpath.2013.08.002_bib14","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","article-title":"Distinctive gene expression patterns in human mammary epithelial cells and breast cancers","volume":"96","author":"Perou","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.08.002_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.08.002_bib16","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.08.002_bib17","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.ejca.2004.08.021","article-title":"Molecular portraits of breast cancer: tumour subtypes as distinct disease entities","volume":"40","author":"S\u00f8rlie","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2013.08.002_bib18","first-page":"81","article-title":"Genomic and molecular classification of breast cancer. Molecular Oncology of Breast Cancer","author":"Sotiriou","year":"2005"},{"key":"10.1016\/j.ajpath.2013.08.002_bib19","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/modpathol.3800678","article-title":"Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile","volume":"19","author":"Dabbs","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.3800570","article-title":"Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer","volume":"19","author":"Bryan","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib21","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/bcr1613","article-title":"Classification of ductal carcinoma in situ by gene expression profiling","volume":"8","author":"Hannemann","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humpath.2006.08.017","article-title":"Identification of a basal-like subtype of breast ductal carcinoma in situ","volume":"38","author":"Livasy","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib23","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr2128","article-title":"Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer","volume":"10","author":"Tamimi","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1078-0432.CCR-07-1127","article-title":"Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution","volume":"14","author":"Allred","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1101\/gr.151670.112","article-title":"Genome evolution during progression to breast cancer","volume":"23","author":"Newburger","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib26","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1172\/JCI33295","article-title":"Breast cancer: origins and evolution","volume":"117","author":"Polyak","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.08.002_bib27","first-page":"144","article-title":"The pathological classification of human mammary carcinoma: past, present and future","volume":"9","author":"Rosen","year":"1979","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.ajpath.2013.08.002_bib28","first-page":"349","article-title":"Recent progress in the histological typing of human breast tumours","volume":"4","author":"van Bogaert","year":"1981","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.08.002_bib30","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.27997","article-title":"Biomarkers for the clinical management of breast cancer: international perspective","volume":"133","author":"Patani","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2013.08.002_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020299707510","article-title":"Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database","volume":"76","author":"Anderson","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2013.08.002_bib34","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1200\/JCO.2005.09.004","article-title":"Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy","volume":"23","author":"Cui","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib35","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1200\/JCO.2007.12.2747","article-title":"Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype","volume":"25","author":"Rakha","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib36","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1210\/endo-103-5-1742","article-title":"Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen","volume":"103","author":"Horwitz","year":"1978","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2013.08.002_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/jclinpath-2012-201148","article-title":"Hormone receptor expression in breast cancer: postanalytical issues","volume":"66","author":"Lee","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib38","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"S\u00f8rlie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.08.002_bib39","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.08.002_bib40","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr433","article-title":"Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer","volume":"4","author":"Sotiriou","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib41","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.08.002_bib42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van \u2019t Veer","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.08.002_bib43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Deconstructing the molecular portraits of breast cancer","volume":"5","author":"Prat","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib45","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2006.07.1522","article-title":"Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade","volume":"25","author":"Loi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2013.08.002_bib47","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","article-title":"Molecular classification and molecular forecasting of breast cancer: ready for clinical application?","volume":"23","author":"Brenton","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2013.08.002_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.11-90001-4","article-title":"Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer","volume":"11","author":"Baselga","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ajpath.2013.08.002_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/cclm.2011.707","article-title":"The human epidermal growth factor receptor 2 (HER2)","volume":"50","author":"Tafe","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ajpath.2013.08.002_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.08.002_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10147-010-0107-0","article-title":"Treatment strategy for HER2-positive breast cancer","volume":"15","author":"Mukai","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrclinonc.2012.36","article-title":"Breast cancer: HER2\u2013a good addiction","volume":"9","author":"Carey","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/COC.0b013e3181b8afcf","article-title":"Triple-negative breast cancer: a short review","volume":"33","author":"Elias","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib54","first-page":"571","article-title":"Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast","volume":"134","author":"Wetzels","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib55","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","article-title":"Epidemiology of basal-like breast cancer","volume":"109","author":"Millikan","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2013.08.002_bib57","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2013.08.002_bib58","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib59","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"Carey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib60","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/2159-8290.CD-12-0462","article-title":"The genomic landscape of breast cancer as a therapeutic roadmap","volume":"3","author":"Ellis","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2013.08.002_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrclinonc.2011.178","article-title":"Practical implications of gene-expression-based assays for breast oncologists","volume":"9","author":"Prat","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib63","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-011-1619-7","article-title":"Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse","volume":"132","author":"Harrell","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2013.08.002_bib64","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jjco\/hyq037","article-title":"Targeted therapy in breast cancer: current status and future directions","volume":"40","author":"Mukai","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib65","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jclinpath-2012-201083","article-title":"Pitfalls in outcome prediction of breast cancer","volume":"66","author":"Rakha","year":"2013","journal-title":"J Clin Pathol"},{"issue":"Suppl 3","key":"10.1016\/j.ajpath.2013.08.002_bib66","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0960-9776(11)70301-0","article-title":"Is gene array testing to be considered routine now?","volume":"20","author":"Paik","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.ajpath.2013.08.002_bib67","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2164-7-278","article-title":"Converting a breast cancer microarray signature into a high-throughput diagnostic test","volume":"7","author":"Glas","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ajpath.2013.08.002_bib68","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jnci\/djj329","article-title":"Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer","volume":"98","author":"Buyse","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2013.08.002_bib69","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.08.002_bib70","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1373\/clinchem.2006.076497","article-title":"Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer","volume":"53","author":"Cronin","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpath.2013.08.002_bib71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/14737159.6.6.803","article-title":"A genetic signature can predict prognosis and response to therapy in breast cancer: oncotype DX","volume":"6","author":"Kaklamani","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ajpath.2013.08.002_bib72","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/annonc\/mds080","article-title":"Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen","volume":"23","author":"Prat","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib73","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/labinvest.2012.91","article-title":"Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue","volume":"92","author":"Potts","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2013.08.002_bib74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jamcollsurg.2012.09.007","article-title":"Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens?","volume":"216","author":"Greer","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ajpath.2013.08.002_bib75","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.08.002_bib76","first-page":"85","article-title":"DNA methylation and epigenetic mechanisms of carcinogenesis","volume":"106","author":"Baylin","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.ajpath.2013.08.002_bib77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-230X(08)60702-2","article-title":"Alterations in DNA methylation: a fundamental aspect of neoplasia","volume":"72","author":"Baylin","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib78","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1158\/1078-0432.CCR-04-0667","article-title":"Hypermethylation in histologically distinct classes of breast cancer","volume":"10","author":"Bae","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib79","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5","article-title":"Epigenetic silencing of maspin gene expression in human breast cancers","volume":"85","author":"Domann","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2013.08.002_bib80","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ijc.11508","article-title":"DNA methylation of RASSF1A, HIN-1, RAR-beta, cyclin D2 and Twist in in situ and invasive lobular breast carcinoma","volume":"107","author":"Fackler","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2013.08.002_bib81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/hmg\/8.3.459","article-title":"Methylation profiling of CpG islands in human breast cancer cells","volume":"8","author":"Huang","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2013.08.002_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(98)00021-3","article-title":"Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells","volume":"210","author":"Jhaveri","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.ajpath.2013.08.002_bib83","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4161\/epi.1.1.2358","article-title":"DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells","volume":"1","author":"Rivenbark","year":"2006","journal-title":"Epigenetics"},{"key":"10.1016\/j.ajpath.2013.08.002_bib84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yexmp.2007.03.008","article-title":"Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions","volume":"83","author":"Rivenbark","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib85","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/labinvest.3700485","article-title":"DNA methylation-dependent silencing of CST6 in human breast cancer cell lines","volume":"86","author":"Rivenbark","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2013.08.002_bib86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1677\/erc.0.0080115","article-title":"DNA methylation in breast cancer","volume":"8","author":"Yang","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ajpath.2013.08.002_bib87","first-page":"6178","article-title":"Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer","volume":"63","author":"Yan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib88","first-page":"3105","article-title":"Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers","volume":"61","author":"Dammann","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.08.002_bib89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1011360724350","article-title":"Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer","volume":"6","author":"Widschwendter","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ajpath.2013.08.002_bib90","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/jnci\/92.10.826","article-title":"Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer","volume":"92","author":"Widschwendter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2013.08.002_bib91","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<833::AID-IJC6>3.0.CO;2-V","article-title":"Hypomethylation of pericentromeric DNA in breast adenocarcinomas","volume":"77","author":"Narayan","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2013.08.002_bib92","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.1083557","article-title":"Chromosomal instability and tumors promoted by DNA hypomethylation","volume":"300","author":"Eden","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.08.002_bib93","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1083558","article-title":"Induction of tumors in mice by genomic hypomethylation","volume":"300","author":"Gaudet","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.08.002_bib94","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1172\/JCI57088","article-title":"Insight into the heterogeneity of breast cancer through next-generation sequencing","volume":"121","author":"Russnes","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.08.002_bib95","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/CCO.0b013e328359554e","article-title":"Next-generation sequencing in breast cancer: first take home messages","volume":"24","author":"Desmedt","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ajpath.2013.08.002_bib96","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/pgs.12.18","article-title":"Next-generation sequencing in breast cancer: translational science and clinical integration","volume":"13","author":"Radovich","year":"2012","journal-title":"Pharmacogenomics"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013005518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013005518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T13:50:37Z","timestamp":1539438637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013005518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0002944013005518"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.08.002","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}